 |
A newsletter for those involved in clinical trials. Published 20 times a
year by Canary LtdJapanese updates
The following articles on this topic have been published in
CRAdvisor (CRA) – the year, issue number
and starting page number for each are listed below:
Back to index |
| 2005 |
|
| CRA 2005; 144:7 |
Japan will require third-party accreditation of low-risk
devices. |
| CRA 2005; 152:3 |
How harmonised is SAE reporting to investigators? |
| |
|
| 2004 |
|
| CRA 2004; 126:6 |
Japanese drug makers look overseas for cheaper trials. |
| CRA 2004; 132:5 |
The EC-Japan MRA. |
| CRA 2004; 134:7 |
Trials to target female population in Japan. |
| CRA 2004; 134:7 |
Japan deregulates 350 drugs. |
| CRA 2004; 135:7 |
New system in Japan. |
| CRA 2004; 138:7 |
Japanese R&D taking shape. |
| |
|
| 2003 |
|
| CRA 2003; 103:8 |
EFPIA Japan. |
| CRA 2003; 104:6 |
SMOs facilitate drug development in Japan. |
| CRA 2003; 108:5 |
Japan's new medical regulatory institution. |
| CRA 2003; 109:6 |
Effects of genome-based medicine on Japanese medical
regulation. |
| CRA 2003; 113:6 |
New law in Japan. |
| |
|
| 2002 |
|
| CRA 2002; 85:6 |
ICH 6 in Japan. |
| CRA 2002; 100:1 |
Brilliance and shadow brought to Japan by ICH. |
| |
|
| 2001 |
|
| CRA 2001; 66:3 |
Role of Head of Medical Institute in Japan. |
| CRA 2001; 69:6 |
Information access in Japan. |
| |
|
| 2000 |
|
| CRA 2000; 57:6 |
Dr Eitaka Tsuboi becomes President of WMA. |
| CRA 2000; 57:6 |
WMA adopts policy on communicable diseases in prisons. |
| CRA 2000; 57:6 |
New policy on organ and tissue transplantation. |
| |
|
| 1999 |
|
| CRA 1999; 28:6 |
Japan to accept foreign data. |
| CRA 1999; 32:6 |
ICH GCP complicates trials in Japan. |
| CRA 1999; 33:4 |
KIKOU advice for trials in Japan. |
| |
|
| 1998 |
|
| CRA 1998; 4:5 |
GCP compliance begins in Japan. |